Get started
MERCK DRNMERCK DRNMERCK DRN

MERCK DRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

MRCK34 trade ideas

MRK LongCompany Profile: Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases Sector(s): Healthcare Industry: Drug Manufacturers—General Top Institutional Holders: Holder Shares Vanguard Group, Inc. (The) : 209,865,924 Blackrock Inc. : 195,017,904 State Street Corporation : 117,030,114
NYSE:MRKLong
by FNKHTrading
MRK - Tripple bottom bounce - target $82Expect to bounce off from $74. Target 82. ——————————————————— How to read my charts? - Matching color trend lines shows the pattern. Sometimes a chart can have multiple patterns. Each pattern will have matching color trend lines. - The yellow horizontal lines shows support and resistance areas. - Fib lines also shows support and resistance areas. - The dotted white lines shows price projection for breakout or breakdown target.
NYSE:MRK
by PaperBozz
MRK - Merck & Co - WEEKLY Setup - Holding the 200emaI Hate Trading Pharma But... MRK BUYZONE = 74 - 76 Cost Avg Down (CAD) = 72 - 70 1st Target = 79 2nd Target = 82 3rd Target = 86 HODL Target = ATH ______________________________________________________________________________________________________________________ This content is for informational, educational and entertainment purposes only. This is not in any way, shape or form financial or trading advice. Good luck, happy trading and stay chill, 2degreez
NYSE:MRKLong
by UnknownUnicorn7216011
Buy $MRK - NRPicks Feb 07Merck & Co, Inc. provides healthcare solutions worldwide. The company offers treatments for cardiovascular disease, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal infections, fungal infections, insomnia and inflammatory diseases; neuromuscular blocking agents; cholesterol-modifying drugs; and vaginal contraceptive and antibacterial products. Merck is one of the companies that had been selected to develop the vaccine; however, it is still a company with a very high level team of workers and successful products. In terms of its finances, its debt is average relative to industry-competitors, plus it generates enough cash to be able to meet those obligations. Fundamentals: - Growth - 6% estimated growth in net earnings for the next 3 years. - ROE 50.5% VS 17% industry. Technicals: - Price level below SMA 250-200-150 - Williams R% at -78% levels - RSI (36) Oversold -1.5% average upside during the month A correction of 11% was presented from JANUARY 12 to FEBRUARY 5, which stopped at $75.45 support. The correction was presented because the company abandoned the development of the vaccine against COVID, from the support the stock has shown a change of trend. Finally, the technical indicators are favorable and give us a buy signal.
NYSE:MRKLong
by NewroadTrader
1
MRK Technical Analysis 🧙Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NYSE:MRKLong
by trading_as_bus
$MRK bear trend will break after (at least) one more swing high.Most of the research is on the page but I'll explain it briefly. The past two clear trends have shown four swing highs before a break (up/down is irrelevant) - the current bearish trend has only seen three swing highs so far. The RSI of the market is low, which usually foreshadows a bullish movement, if you want to argue that the swing high at $84.70 also counts as a swing high in our current bearish trend, then we are just about due for a bullish sprint. I personally don't think we've seen enough swing lows (see previous bear trend) for a momentum break, especially considering that the current trend has the change in CEO & financial report as a catalyst whereas the previous one simply had the financial statement creating momentum.
NYSE:MRKLong
by mjokeym
Traditional|MRK|Long and short *High riskLong and short MRK Activation of the transaction only when the blue zone is fixed/broken. Working out the local support and resistance levels of the triangle. The "forecast" tool is used for more noticeable display of % (for the place of the usual % scale) of the price change, I do not put the date and time of the transaction, only %. The breakdown of the upper blue zone - long. Breakdown of the lower blue zone - short. Working out the stop when the price returns to the level after activation + fixing in the red zone. Blue zones - activation zones. Green zone - take zone. The red zone - the stop zone. Orange arrows indicate the direction of the take. Red arrows indicate the direction of the stop.
NYSE:MRK
by Henry_Ross
2
$MRK ELLIOTWAVESMy current waves on $MRK would love some feedback, this catalyst and original chart was brought up originally by @tomikazi It broke out of the downtrend channel and now is in wave 1. Has a catalyst on Wednesday 1/20/21 PDUFA VII Decision for MRK's Vericiguat: Merck Seeks Approval For Heart Failure Drug Company: Merck & Co., Inc. (NYSE: MRK) Type of Application: NDA Candidate: vericiguat Indication: heart failure Positive ER expected : Merck & Co., Inc.'s earnings, with the lowest EPS estimate coming in at $1.32 and the highest estimate coming in at $1.38. Merck & Co., Inc. reported earnings of $1.16 per share during the same quarter last year, which indicates a positive year over year growth rate of 16.4%. The firm is scheduled to issue its next quarterly earnings report before the market opens on Thursday, February 4th. -Marketbeat
NYSE:MRKLong
by SigCharts
Short Term Idea (Jan 4th 2021 through May 2021)Merck (January 4th 2021 through May 2021) Low: $79 High: $87-$96 Here's my shorter term idea for Merck, couple different possibilities but it does look like it has some gains to make, perhaps all the vaccine news was just at the start. Long term idea is attached below in related ideas: Thanks for tuning in :) Disclaimer, anyone in the trade needs to do their own due diligence and decide what is right for YOU. My charts can be wrong at any time and it's very important that you have your own strategies and plans in place. I run this channel for my own educational purposes of learning to trade, and I will never be 100% right, so please do not let me confirm any bias for you! (Dangerous to do so, stay safe and remember the basics & rules of risk assessment.) Expect the unexpected and happy trading!
NYSE:MRKLong
by Hambooger
Long Term Attempt (Jan 2021)Merck (January 2021+) Low: $41 High: $140 I expect this could be very wrong but I think its still good practice to try and look at major trends before looking at sub-waves. To me it looks like either some sort of giant H&S at the moment or could turn into a channel as well. Related idea has my short term 2021 forecast attached below: Thanks for tuning in :) Disclaimer, anyone in the trade needs to do their own due diligence and decide what is right for YOU. My charts can be wrong at any time and it's very important that you have your own strategies and plans in place. I run this channel for my own educational purposes of learning to trade, and I will never be 100% right, so please do not let me confirm any bias for you! (Dangerous to do so, stay safe and remember the basics & rules of risk assessment.) Expect the unexpected and happy trading!
NYSE:MRK
by Hambooger